Abstract
A series of ten new 2,3,6-substituted quinazolin-4(3H)-one derivatives (10a-j) were prepared from anthranilic acid (1) in a simple and economical path in a series of reactions and screened for their anticancer activity against pancreatic cancer cell line (PANC-1) using MTT assay. The results reveal that at concentration 100 µM/L, compounds 10b, 10f, 10g and 10h exhibited potential anticancer activity by inhibiting the growth of PANC-1 cells by >75% and remaining compounds showed moderate anticancer activity. The structural characterization of the synthesized compounds was elucidated by 1H & 13C NMR, LC-MS, FT-IR and elemental analysis. As potential anti-tumor agents, these new derivatives show promise for further research.
Keywords: Anthranilic acid, Pd catalyst, piperazine, quinazolin-4(3H)-ones, anticancer activity, pancreatic cancer cell line-1 (PANC-1).
Graphical Abstract
Letters in Organic Chemistry
Title:Synthesis, Spectral Characterization and Anticancer Activity of New 2,3,6- Substituted Quinazolin-4(3H)-one Derivatives
Volume: 12 Issue: 6
Author(s): Peddakonda Ramesh, Doddaga Srinivasulu, Polireddy Kishore, Valasani Koteswara Rao and Muttana Vijaya Bhaskara Reddy
Affiliation:
Keywords: Anthranilic acid, Pd catalyst, piperazine, quinazolin-4(3H)-ones, anticancer activity, pancreatic cancer cell line-1 (PANC-1).
Abstract: A series of ten new 2,3,6-substituted quinazolin-4(3H)-one derivatives (10a-j) were prepared from anthranilic acid (1) in a simple and economical path in a series of reactions and screened for their anticancer activity against pancreatic cancer cell line (PANC-1) using MTT assay. The results reveal that at concentration 100 µM/L, compounds 10b, 10f, 10g and 10h exhibited potential anticancer activity by inhibiting the growth of PANC-1 cells by >75% and remaining compounds showed moderate anticancer activity. The structural characterization of the synthesized compounds was elucidated by 1H & 13C NMR, LC-MS, FT-IR and elemental analysis. As potential anti-tumor agents, these new derivatives show promise for further research.
Export Options
About this article
Cite this article as:
Ramesh Peddakonda, Srinivasulu Doddaga, Kishore Polireddy, Rao Koteswara Valasani and Reddy Vijaya Bhaskara Muttana, Synthesis, Spectral Characterization and Anticancer Activity of New 2,3,6- Substituted Quinazolin-4(3H)-one Derivatives, Letters in Organic Chemistry 2015; 12 (6) . https://dx.doi.org/10.2174/1570178612666150320233833
DOI https://dx.doi.org/10.2174/1570178612666150320233833 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Losartan Chemistry and Its Effects via AT1 Mechanisms in the Kidney
Current Medicinal Chemistry Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Cardiovascular Effects of Modulators of Soluble Guanylyl Cyclase Activity
Cardiovascular & Hematological Agents in Medicinal Chemistry Pathophysiology and Pharmacologic Treatment of Venous Thromboembolism
Current Drug Targets Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Current Drug Therapy Ligands of Diltiazem Binding Site: An Overview of Some Chemotypes
Mini-Reviews in Medicinal Chemistry Application of Dual-Source CT Coronary Angiography in Type 2 Diabetic Patients with Symptomatic Coronary Heart Disease
Current Vascular Pharmacology Biologicals Dramatic Advances in the Treatment of Psoriasis
Current Pharmaceutical Design Healthy Properties of Garlic
Current Nutrition & Food Science Microbial Polysaccharides and their Derivatives as Current and Prospective Pharmaceuticals
Current Pharmaceutical Design Pharmacological Therapy of Parkinson’s Disease: Current Options and New Avenues
Recent Patents on CNS Drug Discovery (Discontinued) Management of the Low Cardiac Output Syndrome Following Surgery for Congenital Heart Disease
Current Cardiology Reviews A Key Role for Connexin Hemichannels in Spreading Ischemic Brain Injury
Current Drug Targets Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Recent Advances in the Understanding of Sepsis-Induced Alterations in the Neuroendocrine System
Endocrine, Metabolic & Immune Disorders - Drug Targets Natural Alkaloids and Diabetes Mellitus: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Toxicological Effects of Dietary Biogenic Amines
Current Nutrition & Food Science Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design Advances in L-Type Calcium Channel Structures, Functions and Molecular Modeling
Current Medicinal Chemistry The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function
Current Drug Targets